Scholar Rock Holding (SRRK) Operating Leases (2019 - 2026)
Scholar Rock Holding's (SRRK) quarterly Operating Leases came in at $3.0 million in Q1 2026, down 62.25% year-on-year from $7.9 million in Q1 2025, and down 18.38% quarter-over-quarter from $3.7 million in Q4 2025.
Scholar Rock Holding (SRRK) Operating Leases (2019 - 2026) Analysis & Trends
Scholar Rock Holding's Operating Leases history runs 8 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- On a quarterly basis, Operating Leases fell 62.25% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $3.0 million, a 62.25% decrease from a year earlier, with the FY2025 full-year figure at $3.7 million, down 60.29% from the prior year.
- Operating Leases eased to $3.0 million in Q1 2026 per SRRK's latest filing, from $3.7 million in the prior quarter.
- Across five years, Operating Leases topped out at $17.7 million in Q1 2022 and bottomed at $2.4 million in Q1 2024.
- The 5-year median for Operating Leases is $8.2 million (2023), against an average of $8.7 million.
- Across the five-year window, Operating Leases sank 75.95% in 2024 and soared 227.74% in 2025, its largest moves.
- Year by year, Operating Leases stood at $11.8 million in 2022, then tumbled by 62.78% to $4.4 million in 2023, then jumped by 109.61% to $9.2 million in 2024, then tumbled by 60.29% to $3.7 million in 2025, then slipped by 18.38% to $3.0 million in 2026.
- Per Business Quant, the three latest SRRK Operating Leases figures stand at $3.0 million (Q1 2026), $3.7 million (Q4 2025), and $5.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.98 Mn |
| Dec 31, 2025 | 3.66 Mn |
| Sep 30, 2025 | 5.14 Mn |
| Jun 30, 2025 | 6.56 Mn |
| Mar 31, 2025 | 7.91 Mn |
| Dec 31, 2024 | 9.21 Mn |
| Sep 30, 2024 | 10.47 Mn |
| Jun 30, 2024 | 11.77 Mn |
| Mar 31, 2024 | 2.41 Mn |
| Dec 31, 2023 | 4.39 Mn |
| Sep 30, 2023 | 6.34 Mn |
| Jun 30, 2023 | 8.23 Mn |
| Mar 31, 2023 | 10.03 Mn |
| Dec 31, 2022 | 11.80 Mn |
| Sep 30, 2022 | 13.54 Mn |
| Jun 30, 2022 | 15.65 Mn |
| Mar 31, 2022 | 17.67 Mn |
| Dec 31, 2021 | 19.65 Mn |
| Sep 30, 2021 | 21.60 Mn |
| Jun 30, 2021 | 23.52 Mn |